Guardant Health
Stefanie Mortimer currently serves as Vice President of Technology Research and Senior Director of Technology Development at Guardant Health since May 2021. Additionally, Stefanie is a Board Member at the Gairdner Foundation and a Director At Large for Global Equestrian Imports. Prior experience includes Senior Director of R&D for Single Cell Multiomics at BD from January 2019 to May 2021, and Director of Technology Development at Guardant Health from May 2013 to December 2018, focusing on advancing diagnostic tools for oncology. Academic credentials include a PhD in Biological Chemistry from the University of North Carolina at Chapel Hill and a B.Sc. in Chemistry and Biochemistry from McMaster University. Postdoctoral research was conducted at the University of California, Berkeley, focusing on RNA structure.
This person is not in any teams
This person is not in any offices
Guardant Health
14 followers
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.